Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
Go back to Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.89 -0.25 (6.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.14 | 52 Week High | $45.34 | |||
| Open | $4.15 | 52 Week Low | $15.92 | |||
| Day High | $4.17 | P/E | 1.67 | |||
| Day Low | $3.86 | EPS | $2.33 | |||
| Volume | 3,509,964 | |||||
| (NASDAQ: SOPH) | Delayed: 8.19 -0.34 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.53 | 52 Week High | $ | |||
| Open | $8.55 | 52 Week Low | $ | |||
| Day High | $8.70 | P/E | N/A | |||
| Day Low | $8.12 | EPS | $ | |||
| Volume | 965,128 | |||||
